Health
What are the risks associated with human challenge trials for SARS-CoV-2 vaccine candidates? – News-Medical.Net
Researchers from the University of Haifa, Israel, and WAW Statistical Consulting Ltd, UK, designed a model that helps determine the risks faced by participants…
The timely development of preventive vaccines and new therapeutic drugs will be crucial in managing the burden caused by the coronavirus disease 2019 (COVID-19) pandemic. While there are no approved vaccines for COVID-19 currently, as per estimates, global vaccine production will reach 8 billion doses by 2021, assuming the best vaccine candidate passes clinical trials as expected.
Traditional clinical trials are time-consuming and need a large number of subjects to detect the therapeutic effects…
-
Business20 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News22 hours agoNSW farmer calls for hunting buffer zones after bullets hit property
-
Noosa News20 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business23 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025